Works matching IS 09024441 AND DT 2024 AND VI 112 AND IP 1

Results: 16

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 51, doi. 10.1111/ejh.14132

By:

Gupta, Supriya;
Kohorst, Mira;
Alkhateeb, Hassan B.

Publication type:

Article

Chimeric antigen receptor T‐cell therapy, where are we now and where are we heading for.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 4, doi. 10.1111/ejh.14123

By:

Wang, Liang;
Mei, Heng

Publication type:

Article

Tandem bispecific CD123/CLL‐1 CAR‐T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 83, doi. 10.1111/ejh.14104

By:

Wang, Xiang‐Yu;
Bian, Mei‐Ru;
Lin, Guo‐Qiang;
Yu, Lei;
Zhang, Yan‐Ming;
Wu, De‐Pei

Publication type:

Article

15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 122, doi. 10.1111/ejh.14102

By:

Chatterjee, Gaurav;
Dhende, Priyanka;
Raj, Simpy;
Shetty, Vruksha;
Ghogale, Sitaram;
Deshpande, Nilesh;
Girase, Karishma;
Patil, Jagruti;
Kalra, Aastha;
Narula, Gaurav;
Dalvi, Kajal;
Dhamne, Chetan;
Moulik, Nirmalya Roy;
Rajpal, Sweta;
Patkar, Nikhil V.;
Banavali, Shripad;
Gujral, Sumeet;
Subramanian, Papagudi G.;
Tembhare, Prashant R.

Publication type:

Article

Long‐term survivorship care after CAR‐T cell therapy.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 41, doi. 10.1111/ejh.14100

By:

Puckrin, Robert;
Jamani, Kareem;
Jimenez‐Zepeda, Victor H.

Publication type:

Article

Adverse events and efficacy of second‐round CAR‐T cell therapy in relapsed pediatric B‐ALL.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 75, doi. 10.1111/ejh.14092

By:

Ji, Qi;
Wu, Xiaochen;
Zhang, Yongping;
Zeng, Liang;
Dong, Yi;
Liu, Ruiqing;
Li, Bohan;
Bai, Zhenjiang;
Hu, Shaoyan;
Lu, Jun;
Wu, Shuiyan

Publication type:

Article

Enhanced efficacy of CD19/CD22 bispecific CAR‐T cells with EAAAK linker on B‐cell malignancies.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 64, doi. 10.1111/ejh.14090

By:

Ma, Renyuxue;
You, Fengtao;
Tian, Shuaiyu;
Zhang, Tingting;
Tian, Xiaopeng;
Xiang, Shufen;
Wu, Hai;
Yang, Nan;
An, Gangli;
Yang, Lin

Publication type:

Article

Myocardial strain is associated with adverse cardiac events in patients treated with chimeric antigen receptor (CAR) T‐cell therapy.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 102, doi. 10.1111/ejh.14088

By:

Patel, Nikita P.;
Dalal, Prarthana J.;
Meng, Zhiying;
Baldridge, Abigail S.;
Cascino, Gregory J.;
Sunderraj, Ashwin;
Sinha, Arjun;
Karmali, Reem;
Feinstein, Matthew J.;
Akhter, Nausheen

Publication type:

Article

Case Report: CAR‐T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation.

Published in:

2024

By:

Canale, Filippo Antonio;
Pitea, Martina;
Alati, Caterina;
Porto, Gaetana;
Pratico, Giulia;
Utano, Giovanna;
Germanò, Jessyca;
Imbalzano, Lucrezia;
Ferreri, Anna;
Verduci, Chiara;
Santoro, Ludovica;
Policastro, Giorgia;
Loteta, Barbara;
Pugliese, Marta;
Martino, Massimo

Publication type:

Case Study

CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 6, doi. 10.1111/ejh.14076

By:

Khan, Aalia N.;
Asija, Sweety;
Pendhari, Juber;
Purwar, Rahul

Publication type:

Article

Apheresis collection of mononuclear cells for chimeric‐antigen receptor therapies.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 36, doi. 10.1111/ejh.14071

By:

Maitta, Robert W.

Publication type:

Article

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor‐T cell therapy.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 111, doi. 10.1111/ejh.14068

By:

Yeung, Cecilia C. S.;
Woolston, David W.;
Wu, Vicky;
Voutsinas, Jenna M.;
Basom, Ryan;
Davis, Chris;
Hirayama, Alexandre V.;
Naresh, Kikkeri N.

Publication type:

Article

CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 19, doi. 10.1111/ejh.14051

By:

Fischer, Luise;
Grieb, Nora;
Platzbecker, Uwe;
Vucinic, Vladan;
Merz, Maximilian

Publication type:

Article

Donor‐derived stem cell infusion for sustained pancytopenia after CD19 CAR‐T therapy for relapsed patients post allogeneic stem cell transplantation.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 94, doi. 10.1111/ejh.14050

By:

Li, Yingying;
Li, Yixue;
Zhang, Mingming;
Zhao, Houli;
Zhu, Miaoyong;
Huang, He;
Hu, Yongxian

Publication type:

Article

Chimeric antigen receptor T cells for acute myeloid leukemia.

Published in:

European Journal of Haematology, 2024, v. 112, n. 1, p. 28, doi. 10.1111/ejh.14047

By:

Fetsch, Viktor;
Zeiser, Robert

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2024, v. 112, n. 1, p. 1, doi. 10.1111/ejh.13994
Publication type:: Article